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The neural mechanisms of mindfulness-based pain
relief: a functional magnetic resonance
imaging-based review and primer
Fadel Zeidana,*, Jennifer N. Baumgartnera, Robert C. Coghillb
Abstract
The advent of neuroimaging methodologies, such as functional magnetic resonance imaging (fMRI), has significantly advanced our
understanding of the neurophysiological processes supporting a wide spectrum of mind–body approaches to treat pain. A
promising self-regulatory practice, mindfulness meditation, reliably alleviates experimentally induced and clinical pain. Yet, the
neural mechanisms supporting mindfulness-based pain relief remain poorly characterized. The present review delineates evidence
from a spectrum of fMRI studies showing that the neural mechanisms supporting mindfulness-induced pain attenuation differ
across varying levels of meditative experience. After brief mindfulness-based mental training (ie, less than 10 hours of practice),
mindfulness-based pain relief is associated with higher order (orbitofrontal cortex and rostral anterior cingulate cortex) regulation of
low-level nociceptive neural targets (thalamus and primary somatosensory cortex), suggesting an engagement of unique,
reappraisal mechanisms. By contrast, mindfulness-based pain relief after extensive training (greater than 1000 hours of practice) is
associated with deactivation of prefrontal and greater activation of somatosensory cortical regions, demonstrating an ability to
reduce appraisals of arising sensory events. We also describe recent findings showing that higher levels of dispositional
mindfulness, in meditation-naı¨ve individuals, are associated with lower pain and greater deactivation of the posterior cingulate
cortex, a neural mechanism implicated in self-referential processes. A brief fMRI primer is presented describing appropriate steps
and considerations to conduct studies combining mindfulness, pain, and fMRI. We postulate that the identification of the active
analgesic neural substrates involved inmindfulness can be used to inform the development and optimization of behavioral therapies
to specifically target pain, an important consideration for the ongoing opioid and chronic pain epidemic.
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1. Introduction
Mindfulness-based meditation practice is associated with pro-
moting a wide-spectrum of health outcomes including anxiety,
depression, and pain (see Ref. 22 for thorough review on
mindfulness-based clinical interventions). The advent of modern
neuroimaging and other objective methodological approaches
has substantiated accounts from contemplatives and mindful-
ness practitioners supporting the purported health promoting
benefits of mindfulness-based mental training. We postulate that
the scientific field of mindfulness and other mind–body
approaches has largely advanced because the health promoting
benefits supporting mindfulness are not solely based on sub-
jective reports, but rather, the discovery of the biological
substrates supporting such improvements. The present review
will delineate a brief, yet comprehensive review of the neural
mechanisms supporting pain reductions from the perspective of
interindividual variability in dispositional mindfulness, to brief, and
long-term mindfulness-based mental training. We will also
provide a brief primer to best conduct experiments combining
pain-evoking procedures, mindfulnessmeditation, and functional
magnetic resonance imaging (fMRI).
2. What is mindfulness?
Mindfulness is defined here as nonreactive awareness of the
present moment experience. This construct can be developed
and enhancedwithmindfulness-basedmental training. However,
experience with mindfulness meditation is not a prerequisite to
being mindful.24,32 There are a wide variety of mindfulness-based
practices that are subsumed under the general rubric of
“mindfulness meditation.” Thus, it is critical that the operational
specifics supporting mindfulness practices are fully described to
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promote cross-experimental methodological validity and reliabil-
ity.32,72,103 In the context of the present review, the 2 primary
forms of mindfulness practice are characterized as Shamatha
(focused attention) and Vipassana (open monitoring).72,125
During focused attention practice, or Shamatha,125 the
practitioner is taught to sustain attention on an automatic and
dynamic stimulus, such as breath sensations, as an analogy for
the qualitative aspects of the present moment. As attention drifts
from the object of focus (eg, breath) to a distracting sensory
event, the practitioner is taught to acknowledge the event without
further reaction, to disengage from the discursive event, and then
to return attention to the meditative object (eg, the breath).
Shamatha training increases in complexity (eg, mindfulness of
breath, emotions, and/or thoughts) as individuals develop
expertise at each step. Shamatha practices aim primarily at
gaining mental control and stabilization of attention, thus they
naturally transition in a relatively undefined manner to open
monitoring meditation, or Vipassana practice.
Vipassana meditation has been described as a state of
nonappraisal and/or a nonelaborative mental stance.45,137 In-
deed, there is little to no concrete consensus concerning where
Shamatha ends and Vipassana begins. Vipassana practices are
associated with an awareness of the awareness (ie, meta-
awareness)37,99 of arising sensory, affective, or cognitive events.
The Vipassana practitioner is said to experience each moment
without evaluation or elaborative interpretation.
Traditionally, focused attention is taught before, or as a pre-
requisite to, open monitoring practice. The reason for this is likely
that a greater capacity for attentional stability and mental
control53,138 would allow more success in alleviating one’s
tendency to reflexively engage with, and appraise, ongoing
experience. As the practitioner becomes more adept in medita-
tion, he/shewill be able to use a unique cognitive approachwhere
consciously available sensory events can be simply “let go,”
presumably leading to significant reductions in affective or
cognitive appraisals/reactions to the event. Said another way,
the practitioner “watches” experience as it unfolds over time
without cognitive elaboration or emotional reactivity. As skills in
mindfulness meditation continue to develop, the practitioner
brings mindfulness more effortlessly into meditation and other
aspects of everyday life.59 It is postulated that the state transitions
to a trait as a function of practice frequency and neural plasticity.
However, the cultivation of mindfulness does not exclusively
require training in mindfulness meditation. Some individuals are
simply more “mindful” than others, as evinced by higher scores
on standardized measures of dispositional/trait mindfulness
without any formal training in meditation.24,52,128,142
3. Why mindfulness for pain?
Given that pain is instantiated by a highly distributed network of
brain mechanisms,21 treatments that work in a highly focal
fashion on one neurotransmitter system or on one brain region or
pathway are likely to be of limited efficacy. Treatments that can
target multiple nodes within this distributed network are crucially
needed. Mindfulness may have that ability because it uniquely
enhances cognitive control,138 emotion regulation,73 acceptance
(ie, nonreactivity),68,92,116 and improves mood.17,36 There is also
a great deal of insight from Buddhist contemplatives in the way
that mindfulness-based mental training impacts the subjective
experience of pain. The Sallatha Sutta, a Theravadin Buddhist
scripture from the Pali Canon (translated as The Arrow or The
Dart), explicitly states that there is a key difference in how
mindfulness trained and “untrained” individuals experience pain.3
The Sutta analogizes the reaction to pain to being stung by an
arrow and, in the case of untrained individuals, being struck
immediately after by a second arrow. The 2 arrows are described
as representing physical and mental pain, respectively. The first
arrow could refer to the noxious sensation one initially feels, while
the second dart could be described as the worry, distress, and
pain-evoked suffering that follows. The claim of Buddhist
contemplatives is that mindfully trained individuals, because they
do not cling to sensory pleasure, also do not engage cognitive
and affective appraisals of pain.
4.Doesmindfulnessmeditation relieve chronic pain?
Chronic pain affects more than 100 million Americans, 1.5 billion
people worldwide, and costs the United States an estimated
$635 billion per year in medical expenses and lost work
productivity.33 Despite treatment advances, the pervasiveness
and burden of chronic pain has dramatically increased Medicare
expenditures for steroid injections (↑629%) and opioid treatments
(↑423%).31 The widespread use of opioids to alleviate chronic
pain has led to the so-called “opioid epidemic”84 with an
exponential rise in opioid misuse and addiction.50,98 These
staggering statistics signify the importance of developing fast-
acting nonpharmacologic approaches to treat acute exacerba-
tions of chronic pain. To this extent, the need for effective
nonpharmacological treatment options has spurred much in-
terest in mind–body approaches toward mitigating chronic pain.
Mindfulness meditation-based interventions improve chronic
pain symptomology across a wide range of pain conditions,
including fibromyalgia,29,48 headache disorders,130 chronic
pelvic pain,38 irritable bowel syndrome,41,44 and chronic lower
back pain19,56,58,82,83—the most prevalent and financially bur-
densome chronic pain disorder. Research suggests that mind-
fulness meditation improves chronic pain symptomatology
through unique mechanisms, such as disengagement from
pain-related threat,119 extinction of fear conditioning,
acceptance-based coping strategies,81 and strengthening one’s
ability to self-regulate affective appraisals of nociceptive input.42
Much of the work on the efficacy of mindfulness-based
interventions for the treatment of chronic pain has focused on
outcomes associated with mindfulness-based stress reduction
(MBSR) and its varieties.56,57Mindfulness-based stress reduction
is a structuralized, group-based psychosocial intervention con-
sisting of mindfulness meditation, yoga, and cognitive-behavioral
therapy with the goal of integrating mindfulness into everyday life.
In their seminal work, Kabat-Zinn et al.56 showed that a 10-week
MBSRprogram reduced pain reports, pain-related behaviors and
improved general vitality in chronic pain patients, effects that were
maintained at 15-month follow-up.58 However, this initial work
lacked a control group, and thus, while promising, subsequent
research was warranted. A more recent study showed that
MBSR produced greater reductions in pain catastrophizing in
chronic low-back pain patients compared with cognitive-
behavioral therapy (CBT) and standard of care.118 It is interesting
that MBSR outperformed CBT given the explicit focus of CBT on
controlling maladaptive thoughts and behaviors, suggesting that
mindfulness training may uniquely buffer against future-oriented,
catastrophic thinking. In fact, growing research suggests that the
nonreactivity component of mindfulness is negatively related to
pain catastrophizing.30 However, the long-term benefits of MBSR
on pain catastrophizing are questionable because group differ-
ences were no longer significant at follow-up,118 implying that
training should to be continued to facilitate lasting changes in the
propensity to catastrophize. By contrast, in a seminal study,
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Cherkin et al.19 found that both MBSR and CBT significantly
improved ratings of functional limitations, pain-related distress,
and pain intensity in chronic lower back pain patients when
compared with standard of care. In the same study, findings
persisted for MBSR and CBT at 8-, 26-, and 52-week follow-up,
demonstrating the durability of mindfulness on certain pain-
related outcomes over time. Taken together, this growing body of
work demonstrates that a few weeks of mindfulness training
improves pain and health outcomes in people suffering from
chronic pain, and with some evidence of persistent benefit. Yet,
the precise neural mechanisms supporting pain relief by
mindfulness meditation remains relatively uncharacterized.
5. Multiple neural mechanisms supporting
mindfulness-based pain reductions
Electrophysiological (EEG) and brain imaging methods have
provided an important avenue for elucidating the neural
mechanisms supporting the modulation of pain by mindfulness
meditation. Converging lines of evidence demonstrate that
mindfulness-based analgesia engages distinct neural processes
that vary across training level. Here, we will delineate the neural
mechanisms supporting mindfulness-based pain modulation
across no to brief to long-term training levels. We will focus
primarily on studies using fMRI.
5.1. Brain mechanisms supporting the relationship between
higher trait mindfulness and lower pain sensitivity
Individuals that have never practicedmindfulness meditation may
still be highly mindful as a function of genetics, environment,
psychosocial, and cultural factors. Trait or dispositional mindful-
ness is the innate propensity to be aware of the present moment
in a nonreactive manner.27 Trait mindfulness can also be
developed and increased through mindfulness-based mental
training. Individuals who are low on the trait mindfulness
spectrum exhibit higher pain in a number of clinical pain
populations.81,90,100 Two recent studies combined psychophys-
ics, noxious heat stimulation, and distinct functional neuro-
imaging techniques to identify the neural mechanisms supporting
the postulated relationship between trait mindfulness and pain
sensitivity142 and pain threshold.52 Zeidan et al.142 used
perfusion-based arterial spin labeling (ASL) fMRI to determine
the significant relationship between higher dispositional mindful-
ness (as measured by the Freiburg Mindfulness Inventory) and
lower pain ratings in response to noxious heat (49˚C).142 As
hypothesized, higher trait mindfulness was associated with
greater deactivation of the posterior, midline nodes of the so-
called default mode network. The default mode network is
defined by oscillating activity within a group of distinct brain
regions (medial prefrontal cortex, posterior cingulate cortex
[PCC]/precuneus, inferior, and lateral temporal cortices) and is
associated with facilitating self-referential processes.28,76,91,107
Specifically, greater deactivation of the dorsal PCC and
precuneus was associated with higher trait mindfulness, and
greater activation of the dorsal PCC during noxious heat was
associated with higher pain reports during noxious heat
(Fig. 1).142 In a similar study employing functional connectivity
analyses with blood oxygen level-dependent (BOLD) signaling
fMRI, Harrison et al.52 found that greater trait mindfulness
(measured by the Five Facet Mindfulness Questionnaire) was
associated with higher pain threshold values. Higher trait
mindfulness was associated with weaker connectivity between
the central nodes of the default mode network (ie, medial
prefrontal cortex, PCC/precuneus) and stronger connectivity
between the precuneus and somatosensory cortices. These
findings are remarkably consistent with the principles of
mindfulness supporting the disposition to attend to immediate
sensory aspects of experience and the ability to disengage from
immediate appraisals and corresponding ruminations. Taken
together, these 2 studies provide unique mechanistic insight that
trait mindfulness is associated with lower pain and lower PCC/
precuneus processing, suggesting that trait mindfulness is
associated with a lower propensity to ruminate on65 and
personalize4 the appraisal of arising noxious sensory events.142
Furthermore, individuals who exhibit higher trait mindfulness may
have a greater ability to decouple noxious sensory discriminations
from affective appraisals.142 This is important because even brief
bouts of mindfulness training (less than a week) can significantly
increase dispositional mindfulness on average by
13%.135,138,139,141 These findings could assist us to better
develop and tailor adjunctive pain therapies to specifically target
reductions in PCC/precuneus and increase trait mindfulness
activity to treat pain.
5.2. Neural and physiological processes supporting
mindfulness-based pain relief after brief mental training
Longitudinal and carefully controlled studies examining the
effects of brief mental training regimens can provide insight into
measuring explicit changes in behavioral and physiological pain
responses. To this extent, it is now well established that
mindfulness meditation significantly reduces pain after brief
mental training (4 days . 4 weeks).62,134–136,141 In one of the
first preliminary studies to examine the effects of mindfulness
meditation on pain, Kingston et al.62 found that 6 hours of
mindfulness-based mental training was associated with higher
pain tolerance during the cold pressor test, when compared with
an active, visual imagery-based (“imagine walking through
a garden”) control condition. The authors reported no significant
between-group differences in mindfulness (as measured by the
Kentucky Inventory of Mindfulness Skills), blood pressure, or
mood.62
Others have postulated that mindfulness-induced pain relief
engages mechanisms supporting divided attention, relaxation,
and/or positive mood.15,55 To better address this issue, Zeidan
et al.,138 across 3 separate experiments, dissected the pain
relieving effects of mindfulness meditation regimen (three 20-
minute Shamatha 1 Vipassana training sessions) from a robust,
math distraction and relaxation condition during noxious elec-
trical stimulation. Mindfulness meditation during noxious elec-
trical stimulation significantly reduced pain responses above and
beyond analgesia observed during math distraction and re-
laxation. Surprisingly, mindfulness meditation training signifi-
cantly increased pain threshold when compared with before the
intervention and the control group.138 These findings provided
credence that mindfulness-based pain relief may engage unique
physiological mechanisms from other cognitive techniques to
reduce pain.
In their follow-up study, Zeidan et al.141 examined the
behavioral and neural mechanisms supporting state
mindfulness-induced pain relief before and after a brief, mindful-
ness training regimen (four 20-minute sessions) during noxious
heat (49˚C) in healthy participants. In the pre- and post-fMRI
sessions, participants were instructed to “beginmeditating and to
focus on the changing sensations of the breath” during noxious
heat- and perfusion-based fMRI (ASL). Focusing on the breath
before the intervention reduced pain unpleasantness ratings but
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not pain intensity ratings when compared with rest. After training,
mindful attention to the breath significantly reduced pain intensity
(↓40%) and pain unpleasantness (↓57%) ratings when compared
with rest. Mindfulness meditation produced widespread activa-
tion of the (1) ACC extending from the dACC to the perigenual
ACC (pgACC), (2) bilateral orbitofrontal cortex (OFC), (3) the
primary somatosensory cortices (SI) corresponding to the face
region, (4) bilateral ventral striatum, and (5) deactivation of the
default mode network.141 In the presence of noxious heat,
mindfulness significantly reduced SI activation corresponding to
the stimulation site (right leg), suggesting that mindfulness
reduces ascending nociceptive inputs to somatosensory cortical
regions. Regression analyses revealed that greater pain relief was
directly associated with greater activation of the pgACC, right
anterior insula, and bilateral OFC. Greater mindfulness-based
pain relief was also associated with significant extensive, bilateral
deactivation of the thalamus, a critical node of ascending
nociceptive information from the spinal cord (Fig. 1).49 These
findings are particularly consistent with the principles of
mindfulness. That is, the pgACC facilitates top-down regulation
of negative effect, affective modulation of pain, and autonomic
regulation.11,16,101,120,121 The right anterior insula has been
repeatedly implicated in processing interoceptive awareness
and regulation of nociception.20,21,26,64,86,109,111 The OFC,
a highly evolved brain region, is associated with increasing
positive mood and altering the contextualization of arising
sensory events.35,85,88,94 We propose a working theoretical
framework that connects mindfulness-based pain relief with
multiple, neural mechanisms that support both cortico-cortical
and cortico-thalamo-cortical interactions.
Randomized, placebo-controlled studies are characterized as
the “gold standard” to defining the effectiveness and active novel
pain relieving treatments. Yet, placebo-controlled meditation
studies have been very limited. This is problematic when
considering that meditation is very susceptible to placebo
responses and nonspecific effects such as slow breathing,
demand characteristics, beliefs related to practicing meditation,
conditioning, posture, among others. Thus, in the follow-up
experiment, Zeidan et al.135 examined if the physiological and
neural (ASL fMRI) mechanisms supporting mindfulness-based
pain relief are distinct from those engaged by different placebo
conditions. Healthy, pain-free participants were randomly
Figure 1. First row (dispositional mindfulness): Greater deactivation of the posterior cingulate cortex (PCC)/precuneuswas associatedwith higher trait mindfulness
(Freiburg Mindfulness Inventory) and lower pain during noxious heat stimulation.142 Second row (brief mindfulness training): Higher mindfulness meditation-
induced activation of the bilateral orbitofrontal cortex (OFC), rostral anterior cingulate cortex (rACC), and greater thalamic deactivation was associated with greater
pain relief during noxious heat.141 Third row (extensive mindfulness training): When compared with age-matched controls, adept Zen meditators exhibited
significant decoupling in low-level pain-related brain activation (thalamus) and brain regions that process appraisals and affect (medial OFC [mOFC] and
dorsolateral PFC [DLPFC]) during noxious heat stimulation.45
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assigned to 1 of 4 (four 20-minute/session) training regimens: (1)
a mindfulness meditation akin to one previously described, (2)
a placebo cream conditioning, (3) a sham mindfulness medita-
tion, and 4) a book-listening control. Participants in the placebo-
conditioning group were led to believe that the effects of an
experimental form of Lidocaine was being evaluated, in which the
pain-relieving effects of the cream (petroleum jelly) progressively
increased with repeated application. Participants were led to
believe that the cream was analgesic by covertly reducing
stimulus temperature after application of the cream in each
conditioning session. The sham mindfulness regimen mirrored
mindfulness meditation on all nonspecific and psychosocial
factors (posture, breathing, and eyes closed), but without the
explicit training on focusing on the changing sensations of the
breath in a nonreactive fashion. Thus, this group (theoretically)
allowed us to disentangle the active mechanisms that were
specific to mindfulness. All conditions significantly reduced pain
intensity and pain unpleasantness ratings compared to the book-
listening controls. Mindfulness meditation was more effective
than placebo cream, placebo (sham) mindfulness, and control
conditions at reducing pain ratings. The neural mechanisms
supporting mindfulness-based pain relief were, again, found to
be associated with greater activation in the OFC, pgACC, and
right anterior insula.135 There was also significant deactivation of
the PAG and thalamus, replicating and extending on the findings
described in the previous ASL study.141 Placebo cream-induced
pain relief was associated with significant reductions of contra-
lateral, nociceptive somatosensory areas (ie, parietal operculum
and secondary somatosensory cortices [SII]) and greater
activation of the dorsolateral prefrontal cortex [DLPFC]), likely
reflective of perceive controllability of pain5,97,102 and lower
expectations for pain.6,64 This was the first ASL fMRI placebo
experiment and largely replicated the findings supporting other
pain-placebo–focused brain imaging studies.11,14,63,64,70,122,123
Regression analyses revealed that sham mindfulness induced
pain relief was associated with lower respiration rate. These
findings provide clear mechanistic distinctions between mind-
fulness and placebo. As described earlier, mindfulness engages
multiple mechanisms supporting top-down regulation of pain. By
contrast, shammindfulness meditation likely employs bottom-up
processes. Taken together, these findings provide robust
evidence that the state effect of mindfulness meditation, after
brief mental training, significantly reduces pain and recruits
multiple, distinct neural processes from robust placebo
conditions.
6. Neural mechanisms supporting pain relief after
extensive mindfulness meditation experience
Research employing individuals with extensive mindfulness med-
itation experience (.1000 hours of practice) has provided insight
into the ability of adept practitioners to evokemore stabilized, state-
and trait-level changes in nociceptive processing, and correspond-
ing pain responses. There is reliable and growing evidence
demonstrating that long-term mindfulness practice can lead to
significant increases in pain threshold values and lower pain
sensitivity even when participants are not explicitly practicing
mindfulness.13,19,43,46,82,83 Grant and Rainville46 were the first to
demonstrate that adept Zen practitioners (a mindfulness practice
similar to Vipassana) required significantly higher noxious heat
stimulation to report the same level of pain as age-matched
controls. In a follow-up fMRI (BOLD) study using a functional
connectivity analyses during noxious heat stimulation and over-
lapping participant sample, Zen practitioners exhibited a significant
decouplingbetween brain regions supporting nociceptive process-
ing (thalamus; insula; SII) and sensory/affective appraisal (dlPFC;
dACC) when compared with age-matched controls (Fig. 1).45
Greater decoupling between these brain regions was associated
with higher pain tolerance in the Zen group. The authors postulated
that the Zen practitioners preserved the capacity to attend to
sensations but reduced affective appraisals of said sensory events.
Importantly, practitioners were not meditating in this study,
potentially providing credence of longstanding Buddhist accounts
implicating extensive mindful practice with pronounced, trait-like
changes in subjective experience and perception. Another study
examined the state effects of mindfulness on pain responses and
corresponding brain mechanisms (BOLD fMRI) in long-term
Vipassana practitioners and demographically matched meditation
naı¨ve controls.40 Practicing mindfulness in response to 1-second
noxious electric stimuli reduced pain unpleasantness (↓22%) and
anticipatory anxiety (↓29%) ratings when compared with rest and
control conditions. Surprisingly, mindfulness meditation did not
significantly reduce pain intensity ratings when compared with
controls. Mindfulness-based pain relief was associated with
decreased activation in the lateral PFC and increased activation
in the right posterior insula/SII.40 The authors postulated that this
reflects “decreased cognitive control.” One could also take the
perspective132,137,143 that mindfulness was associated with
enhanced cognitive flexibility, potentially reflected by observed
increases in rACC during meditation. Other groups45,114 have also
postulated that it requires a significant degree of cognitive-affective
control to reduce appraisals (↓PFC) of ascending noxious sensory
events.
To this extent, one of the defining features of mindfulness
meditation is the emphasis on nonevaluative awareness of
present moment experience. It can reasonably be construed,
then, that this experiential acceptance should reduce expect-
ations of impending noxious stimuli that could exacerbate the
pain experience.64,140 Lutz et al.71 tested this postulation by
examining the influence of long-term mindfulness meditation
(.10,000 hours of practice in the Nyingma and Kagyu traditions
of Tibetan Buddhism) on psychophysical and neural responses to
noxious heat stimulation. Control participants were nonmedita-
tors that were instructed to practice mindfulness at home for 1
week. Surprisingly, both adept and novice meditators reduced
pain intensity ratings during Shamatha practice and noxious heat,
and there were no significant group differences. Vipassana-
based meditation produced significant pain unpleasantness
reductions in the adept meditators when compared with novices.
The adept meditators exhibited less activation in the contralateral
anterior insula and the rostral aspect of the midcingulate cortex
during the prestimulus period when compared with controls.
Furthermore, the greater the meditative experience, the greater
the deactivation of said regions. Brown and Jones13 used
electroencephalography (EEG) and pain-evoking laser stimula-
tion to examine behavioral and EEG pain responses in adept
meditators. Similar to Lutz et al., they found that lower pain
responses were associated with significantly lower anticipatory
event-related potentials in the inferior parietal and midcingulate
cortex in the meditation but not control group.13 Greater
meditative experience also predicted lower anticipatory EEG
responses and greater pain relief. Remarkably, these effects were
detected during a nonmeditative state and provided a clear scope
of the trait-like pain modulatory changes that can occur with
extensive mindfulness training.13 Finally, in a recent preliminary
study, Taylor et al.115 recruited 11 adept meditators (.1000
hours of training in the Zen, Bodhicitta, and Kadampa tradition)
and 51 control subjects to examine whether mindfulness reduces
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pain and anticipatory skin conductance reactions, specifically the
nociceptive flexion reflex, in response to a fear condition task and
noxious electrical stimulation. They found that the meditation
group exhibited less pain sensitivity and reduced fear-induced
pain facilitation than controls. Meditators and nonmeditators
displayed comparable nociceptive flexion reflexes, suggesting
that mindfulness does not (1) modulate nociceptive processes at
the level of the spinal cord, (2) engage classical descending
inhibition of pain mechanisms, and (3) reduce anticipatory
responses corresponding to conditioned pain-focused fear
response, but rather direct expectations of impending stimuli,
a finding consistent with previous work.13,71 The authors further
speculated that reductions in fear-conditioned pain learning
might be a mechanism by which mindfulness reduces the
progression of acute to chronic pain. Taken together, these
mechanistic findings13,71,115 show that attenuating the expect-
ations of impending sensory events by sustaining attention in the
present moment are directly associated with facilitating
mindfulness-based pain relief.
7. The role of endogenous opioidergic systems (or
lack thereof) in mindfulness-induced pain relief
A plethora of endogenous neurotransmitters, including the
cannabinoid, serotonergic, dopaminergic, and opioidergic sys-
tems, at least, are partially engaged in the cognitive modulation of
pain.7,127 To date, the endogenous opioidergic system is
characterized as the primary endogenous pain modulatory
system.127 Higher order brain regions (PFC; rACC) project to
the PAG, the rostral ventral medulla, and the dorsal horn of the
spinal cord to reduce the elaboration of spinal and supraspinal
nociceptive processing through the release of endogenous
opioids9,77,78 that largely bind with mu, delta, and kappa
receptors.54,69 Pain relief produced by placebo,2,34,47,67,147
acupuncture,51 conditioned pain modulation,61 distraction,108
and hypnosis39,110 is meditated, in part, by endogenous
opioidergic systems.
Mindfulness-based analgesia, after brief mental training, is
associated with greater activation of the rACC, OFC, and insular
cortices, brain regions that contain high concentrations of opioid
receptors.18,117,124 However, mindfulness meditation also deac-
tivates the PAG, a central node in opioidergically mediated
descending inhibition of pain.7 To bridge this exploratory gap,
Zeidan et al.134 conducted a double-blinded, randomized study
of healthy, meditation-naı¨ve participants to determine whether
mindfulness pain relief engages endogenous opioids in response
to intravenous administration (IV) of placebo saline and high-dose
naloxone, the opioid antagonist, when compared with a book-
listening control. In brief, mindfulness, after brief mental training,
effectively reduced behavioral responses in the presence of
opioid blockade and saline, demonstrating that mindfulness-
based analgesia is not mediated by endogenous opioids. As
a supplementary query, one could postulate that mindfulness-
based pain relief, after extensive mindfulness training, could
engage endogenous opioidergic systems due to progressive
development of opioidergically driven processes such as
conditioning, expectations, and other placebo-type mecha-
nisms. Using a double-blinded, cross-sectional design, May et al.
(2018) assessed the role of endogenous opioids in mindfulness-
based pain relief in adeptmindfulness practitioners with extensive
training (.4,000 hours of practice). Surprisingly, when compared
with saline and the control group, high-dose IV naloxone infusion
produced greater pain relief in the meditation group, providing
further evidence that mindfulness across training levels produces
analgesia independent of endogenous opioids.79 We postulated
that expert meditators may have exerted more effort in the
presence of naloxone to counteract the effect of naloxone, and
that other nonopioidergic systems10 may have been engaged to
compensate for opioid blockade.89 By contrast, another group
used a randomized, crossover design and reported that
mindfulness-based pain relief was reversed by naloxone105 in
response to a brief (10 seconds) noxious cold stimulus. In our
rebutting commentary of this study, we postulated that the
authors’ interpretations were not justified because of the
significant decrease in pain (ie, ↓19%) during mindfulness and
naloxone infusion and the comparable reductions during
meditation and saline infusion (ie, ↓25%).133 Importantly, the
authors did not directly statistically compare the differences in
pain between the saline and naloxone conditions, which begs the
question on why they used the elegant crossover-controlled
design. The authors go on to say in their rebuttal to our
commentary104 that “experience seems to be a crucial factor in
opioid involvement in mindfulness meditation.” Our recent study
demonstrating that mindfulness-based analgesia is more pro-
nounced during naloxone in long-term meditators (mean
experience .4000 hours of meditation practice) potentially
invalidates this interpretation.79 Taken together, these findings
are important because they provide supplementary evidence that
mindfulness engages uniquemechanisms to reduce pain that are
distinct from those mediated by placebo analgesia (ie, endoge-
nous opioids; ↓ PAG). Because opioid and nonopioid processes
synergistically interact with reduce pain, these findings suggest
that mindfulness could be used in conjunction with traditional
pain therapies to optimize analgesia, an important finding for the
millions of chronic pain patients seeking effective, self-regulatory
pain therapy.
8. A brief primer: functional neuroimaging of
mindfulness and pain
The widespread employment of functional neuroimaging method-
ologies and identification of the health promoting mechanisms
supporting meditation is credited with the explosive proliferation of
mindfulness-based research. Functional magnetic resonance
imaging, positron emission tomography (PET), and ASL fMRI have
provided means to collect direct (perfusion-based fMRI; PET) and
indirect (BOLD; fMRI)measures of cerebral blood flow (CBF),which
provide higher spatial resolution (ie, indicating where neural activity
may be occurring), although this comes at a tradeoff, with poorer
temporal resolution (2–5 seconds) than EEG/event-related
potential. Here, we will provide very brief suggestions on how to
best conduct mindfulness-pain research in combination with fMRI.
8.1. Arterial spin labeling or blood oxygen level–dependent
functional magnetic resonance imaging to study state
mindfulness and pain?
Both ASL and BOLD fMRI examine CBF to make inferences
about neural activity. There are a number of reasons that we
propose that perfusion-based, ASL fMRI method is more
appropriate for examining the effects of state mindfulness
meditation when comparedwith BOLD fMRI. Arterial spin labeling
fMRI provides a fully quantifiable and direct measurement of CBF
(mL/100 g of tissue/min). By contrast, BOLD is an indirect
surrogate of CBF that assesses blood oxygen in arbitrary units.
When compared with BOLD fMRI, ASL is less sensitive to low-
frequency drifts in signal intensity that can occur as an individual’s
body relaxes as a function of time or as the scanner heats up over
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the course of an imaging series.126 Accordingly, BOLD fMRI is not
well suited to appropriately image task-related brain activation
longer than 30 seconds.1 Furthermore, when compared with
BOLD, ASL fMRI can reliably assess rostral neural regions, such
as the OFC,126 a brain area repeatedly implicated in mindfulness
meditation,135,141 but suffering from substantial susceptibility
artifacts. Nevertheless, BOLD fMRI does enjoy higher signal-to-
noise ratio when compared with ASL.87 Thus, the utility of ASL vs
BOLD comes down to the primary aims of the study.
8.2. State mindfulness produces respiration-induced
functional magnetic resonance imaging artifacts
As fMRI scanners increase their respective field strengths,
physiological noise has become a significant confound reducing
the applicability and generalization of functional neuroimaging
findings.93 This is an important caveat because state mindfulness
meditation reliably (1) reduces respiration rate and, in parallel,
decreases CBF due to lower arterial levels of carbon dioxide60,131
and (2) alters chest movements that cause magnetic field
changes, rendering a physiological artifact.112 This is problematic
because meditation-induced changes in breathing are directly
task-specific and can dramatically misconstrue the interpretation
of findings. The changes in breathing aremeditation-specific, and
the brain (de) activations could be interpreted as meditation-
related mechanisms, when they are potentially due to physio-
logical noise.12,96 In our laboratory, we have seen (unpublished
findings) significantly greater white-matter activation when
compared with gray matter during meditation practice. One can
make the mistake of regressing out each individual’s respiration
rate from his or her respective fMRI analysis. However, that would
likely remove neuronal activation that directly corresponds to
mindfulness-based breath focus, as opposed to controlling for
physiological noise. Furthermore, the employment of perfusion
fMRImay not directly correct for physiological artifacts, although it
is better suited to identify if CBF deviations occurred (ie, ASL
produces fully quantifiable CBFmeasurements). Thus, it is critical
that researchers evaluate and correct for this issue by (1)
collecting respiration data, (2) visually inspecting data for
significantly greater white-matter activation when compared with
gray matter, (3) segmenting and comparing white-matter and
gray-matter brain, and (4) inputting segmented white values as
covariates of no interest in the statistical analyses using
a component-based noise correction method (CompCor; tem-
poral or anatomical variants).8
8.3. ON/OFF block functional magnetic resonance imaging
designs are not appropriate to examine state mindfulness
Functional neuroimaging experiments use “ON/OFF” block designs
to identify brain activation corresponding to any specific event (eg,
noxious stimulation; cues; appraisals corresponding to a stimulus,
etc.). For example, a traditional BOLD-based fMRI experimental
paradigmmaybedesigned to contrast brain activation in response to
10-second plateaus of noxious, 49˚C and innocuous 35˚C heat,
respectively. The 49˚ stimulus is generally characterized as the “on”
and 35˚C as the “off” condition, respectively. Because this
hypothetical experimental paradigm controls for contact of the
thermal probe and change in stimulus temperature, significant brain
activation could be interpreted asbrain activity corresponding to 49˚C
when compared with 35˚C, and vice versa. However, this on–off
paradigm cannot be used to measure state mindfulness. That is,
directing subjects to meditate for 10 seconds (ON) and rest (OFF) for
10 seconds will lead to contamination of the “OFF” period because
the cognitive state of mindfulness meditation cannot be “turned off
and on” like a thermal stimulus. There are carryover effects from
mindfulness meditation that can last minutes to days. Thus, we
propose starting the experiment with rest (ie, nonmeditation) for the
first half of the experiment and instructing subjects to meditate in the
second half of the study. This paradigm is weakened by obvious
order effects, but usingaparallelingnonmanipulationgroup/condition
can easily control this for experimental confound. It is important to
note that these recommendations are explicit to state mindfulness
meditation activation studies. It is perfectly acceptable to use BOLD
fMRI-based resting state functional connectivity analyses tomeasure
stabilized changes in neural functioning because ASL fMRI is not yet
optimized for connectivity studies.
8.4. Strong control conditions are critical to disentangle
mechanisms supporting mindfulness-based analgesia
The neural mechanisms supportingmindfulness-based practices
still remain poorly characterized.113Mindfulness-based pain relief
is believed to be associated with a spectrum of nonspecific
factors such as distraction, slow breathing, placebo, condition-
ing, facilitator attention, social support, body posture, relaxation,
and demand characteristics. This is a limitation in fostering the
validity of this practice to relieve pain. We suggest that
mindfulness-pain neuroimaging studies should use comparison
conditions that most closely resemble mindfulness practices and
suited to disentangle the mechanisms that are postulated to be
engaged by mindfulness. To better address this issue, we
recently developed and validated a sham-mindfulnessmeditation
comparison condition.135,139 Sham-mindfulness meditation (ie,
placebo mindfulness) was designed, so that the primary
difference between the mindfulness and sham-mindfulness
practice was the explicit instructions corresponding to the
nonreactive attention to the breath sensations used in the
mindfulness meditation. Participants were first instructed that
they were randomly assigned to the mindfulness meditation
group, and that mindfulness training was secular. In each of the
training sessions, subjects were instructed to close their eyes,
and to take a deep breath “as we sit here in meditation” every 2 to
3 minutes.135,139 All other aspects of the sham-mindfulness
meditation intervention (ie, posture, training room, facilitator; time
spent providing instructions; and eyes closed) matched the
mindfulness meditation-training regimen. We also paralleled the
fMRI-session’s experimental directives (“begin practicing mind-
fulness meditation until the end of the experiment”) across the
mindfulness and sham-mindfulness groups.
Other appropriate fMRI controls for mindfulness include divided
attention tasks,55,106,136 relaxation conditions,136 cognitive-
behavioral therapies, and techniques that may share mechanisms
that may be engaged by mindfulness (ie, slow breathing
manipulations). Some recent studies have successfully disen-
tangled the active mechanisms supporting mindfulness-based
health promotion. Creswell et al.23 compared behavioral, inflam-
matory stress [ie, interleukin-6 (IL-6)] and neural mechanisms
supporting an intensive 3-day mindfulness meditation and 3-day
health enhancement relaxation program in unemployed and
clinically stressed adults. All aspects of the relaxation program
were matched to the mindfulness regimen intervention (including
time of the interventions held on the same weekends and even the
location of the intervention). Mindfulness-induced stress reductions
were associated with stronger functional connectivity between the
PCC and dlPFC, mechanisms supporting executive-level control of
emotions. By contrast, the relaxation group exhibited higher IL-6
responses after the intervention. Another group used a health
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enhancement program (HEP) to disentangle the mechanisms
supporting mindfulness.74,75,95 The HEP controlled for facilitator
allegiance, social support, and other components related to
participating in a mindfulness program. Although the HEP and
mindfulness conditions were effective at improving mood, stress,
and cognition, they did not significantly differ. However, the
mindfulness program was more effective at reducing inflammatory
markers in response to a social stress test95 and pain.74 Taken
together, these findings demonstrate that some mindfulness
techniques are not more beneficial than active controls on some
health outcomes (stress and cognition) but superior on other
outcomes (pain). Nevertheless, they demonstrate that mindfulness
engages unique health-promoting mechanisms that are important
to better optimize the development and tailoring of said interven-
tions for different patient populations.
8.5. Mindfulness training for the scanner
In light of the ongoing opioid epidemic, nonpharmacological pain
therapies such as mindfulness-based approaches will continue to
be examined by combining subjective reports and functional
neuroimaging methodologies. We have provided a number of
supplementary suggestions thatmay aid in conductingmindfulness-
pain fMRI studies. Practicing mindfulness meditation is quite difficult
to perform in a quiet room. Mindfulness practice difficulty is
exacerbated in the fMRI environment. The scanner (1) is very loud,
(2) confines the individual, and (3) renders the participant unable to
practice mindfulness in an upright, seated position. To address this,
we andothers66 have conductedmindfulness trainingwhile subjects
are lyingdownandduring an audio recordingof the scanner sounds.
We initially begin our mindfulness training regimens while subjects
are in amore traditional pose (ie, sittingup in a chair) and then instruct
individuals to lie in the supine to practice with the sounds of the
scanner (after the first, 3 training sessions). We also recommend
conducting mindfulness training in a “mock scanner” or a similar
environment to better control for claustrophobic individuals and to
better prepare subjects to meditate in the scanner.
9. Considerations and future steps for mindfulness-
based pain research
Here, we show that mindfulness meditation-based pain relief does
not engage one particular brain mechanism to reduce pain, but
rather a combination of processes that are reflective of effortful,
reappraisal processes. In light of Francis Crick’s “speculative…
searchlight hypothesis,”25,80 we propose that the observed
relationship between mindfulness-based pain relief and thalamic
deactivation reflects a remote tuning mechanism that is facilitated
by feedback connections between excitatory, glutamatergic OFC
innervations on the thalamus and subsequently the inhibitory,
GABAergic thalamic reticular nuclei (TRN).144–146 Coincidently,
these neuroanatomical projections (OFC . TRN) reflect a gating
mechanism of ascending sensory information that selectively
modulates, through higher order cognitive control processes (ie,
focusing on breath sensations), sensory and emotional salience of
said sensory events to significantly reduce the thalamic trans-
mission to early somatosensory cortices (ie, SI). This mechanism is
critically involved in integrating real-time sensory and affective
information,129 assessing value,49 and regulating “passage to the
cortex”.146 Unfortunately, ASL fMRI does not provide optimized
means to directly test this hypothesis using functional connectivity
analyses, due to low signal-to-noise resolution. Nevertheless,
these findings demonstrate that mindfulness-based pain relief
engages multiple brain mechanisms that are relatively distinct from
other cognitive manipulations. Importantly, the Zeidan et al. (2011)
study lacked a matched and active control group, and thus, it was
difficult to explicitly ascertain whether mindfulness reduces pain
through brain mechanisms that are reflective of placebo analgesia.
The postulated mechanisms supporting mindfulness-based
pain relief may not explicitly relate to eradicating the intensity of
pain but suggest that mindfulness alters the contextual evaluation
of innocuous and noxious sensory events. Mindfulness medita-
tion, across all reported pain focused studies, impacted the
affective dimension of pain more so than sensory pain. However,
more brain imaging research is needed to clearly extrapolate the
mechanisms that mindfulness impacts chronic pain, as the large
proportion of said fMRI-mindfulness studies were conducted in
healthy individuals. To this extent, it will no doubt be fruitful to
incorporate PET studies to better identify neurochemical-based
interactions supporting mindfulness-based analgesia. This line of
research would, if properly designed, provide a clear un-
derstanding of the different classes of neurotransmitters involved
in mindfulness and provide another means of testing our working
hypothesis on the role of the TRN inmodulating pain. Mindfulness
is susceptible to nonspecific effects, thus we highly recommend
appropriate placebo-based comparisons to better isolate genu-
ine mindfulness mechanisms. We also need to better character-
ize the neural mechanisms supporting mindfulness-based pain
relief in specific chronic pain populations. For instance, the neural
processes supporting pain relief in chronic low-back pain may
differ from those found to be effective at treating migraine pain.
We also need to appreciate how long the effects ofmeditation last
and how much training is required. Nevertheless, it is clear that
mindfulness effectively reduces pain and does so by engaging
processes that reflect changes in one’s relationship with re-
spective pain. This is important for those seeking ways to reduce
the impact of developing chronic pain and the common
comorbidities (anxiety and depression) that exacerbate the pain
experience. We predict that the mechanisms supporting
mindfulness-based pain relief become more robust with more
practice, a distinction from traditional pain therapies that exhibit
increasing tolerance and plateaus in efficacy. When considering
the ongoing chronic pain and opioid epidemic, the utility of
mindfulness meditation may prove to be an important tool to
teach individuals to self-regulate pain directly with a present-
centered and acceptance-based strategy.
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